{
  "source": "MFN",
  "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
  "retrieved_at": "2026-08-07T03:29:41Z",
  "status": "retrieved",
  "resolution": {
    "status": "resolved",
    "company_name": "EQL Pharma",
    "expected_name": "EQL Pharma",
    "match_score": 100.0,
    "slug": "eql-pharma",
    "url": "https://mfn.se/all/a/eql-pharma",
    "metadata": {
      "country": "Sverige",
      "list": "Small Cap Stockholm",
      "sector": "Hälsovård",
      "industry": "Läkemedel & Handel",
      "website": "https://mb.cision.com/Main/11664/4377852/4203751.pdf"
    },
    "ticker_candidates": [],
    "attempts": []
  },
  "releases": [
    {
      "source": "MFN",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:29:41Z",
      "company": "EQL Pharma",
      "issuer_match_score": 9.694915254237287,
      "title": "Bokslutskommuniké april 2025 - mars 2026",
      "date": "2026-05-08",
      "report_type": "year-end-report",
      "fiscal_year": 2026,
      "quarter": "q4",
      "period": "2026-q4",
      "report_key": "2026:q4",
      "release_url": "https://mfn.se/cis/a/eql-pharma/bokslutskommunike-april-2025-mars-2026-cd65bce1",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\reports\\2026-05-08-bokslutskommunike-april-2025-mars-2026\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\reports\\2026-05-08-bokslutskommunike-april-2025-mars-2026\\release.txt",
      "attachments": [
        {
          "label": "PDF",
          "url": "https://mb.cision.com/Main/11664/4346191/4083691.pdf",
          "final_url": "https://mb.cision.com/Main/11664/4346191/4083691.pdf",
          "filename": "4083691.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\reports\\2026-05-08-bokslutskommunike-april-2025-mars-2026\\4083691.pdf",
          "content_type": "application/pdf",
          "size": 613524,
          "sha256": "243bec63f15471136e369b234f362772ed692471915062c0de56f5f1daf47455",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\reports\\2026-05-08-bokslutskommunike-april-2025-mars-2026\\4083691.pdf",
            "filename": "4083691.pdf",
            "extension": ".pdf",
            "size": 613524,
            "sha256": "243bec63f15471136e369b234f362772ed692471915062c0de56f5f1daf47455",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\reports\\2026-05-08-bokslutskommunike-april-2025-mars-2026\\extracted\\4083691\\4083691.txt",
            "text_chars": 41933,
            "metadata": {
              "page_count": 21,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\reports\\2026-05-08-bokslutskommunike-april-2025-mars-2026\\extracted\\4083691\\4083691.extraction.json"
          }
        }
      ],
      "status": "retrieved"
    }
  ],
  "skipped_because_nasdaq": [
    {
      "report_key": "2026:annual",
      "title": "EQL Pharma Årsredovisning 2025/2026",
      "date": "2026-07-24",
      "url": "https://mfn.se/cis/a/eql-pharma/eql-pharma-arsredovisning-2025-2026-a44358e6"
    },
    {
      "report_key": "2025:q1",
      "title": "EQL Pharma: Interim Report April - December 2025",
      "date": "2026-02-03",
      "url": "https://mfn.se/cis/a/eql-pharma/eql-pharma-interim-report-april-december-2025-297b3c00"
    },
    {
      "report_key": "2026:q1",
      "title": "Bulletin from the extraordinary general meeting in EQL Pharma AB on 3 February 2026",
      "date": "2026-02-03",
      "url": "https://mfn.se/cis/a/eql-pharma/bulletin-from-the-extraordinary-general-meeting-in-eql-pharma-ab-on-3-february-2026-950081cc"
    },
    {
      "report_key": "2025:q3",
      "title": "EQL Pharma: Interim Report April - September 2025",
      "date": "2025-11-05",
      "url": "https://mfn.se/cis/a/eql-pharma/eql-pharma-interim-report-april-september-2025-357d38e6"
    },
    {
      "report_key": "2025:q2",
      "title": "EQL Pharma: Halvårsrapport April - september 2025",
      "date": "2025-11-05",
      "url": "https://mfn.se/cis/a/eql-pharma/eql-pharma-halvarsrapport-april-september-2025-5474fd43"
    }
  ],
  "metadata": {
    "country": "Sverige",
    "list": "Small Cap Stockholm",
    "sector": "Hälsovård",
    "industry": "Läkemedel & Handel",
    "website": "https://mb.cision.com/Main/11664/4377852/4203751.pdf"
  },
  "ticker_candidates": [],
  "company_url": "https://mfn.se/all/a/eql-pharma",
  "company_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\company.txt",
  "company_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\mfn\\company.html"
}